全文获取类型
收费全文 | 32245篇 |
免费 | 3105篇 |
国内免费 | 125篇 |
专业分类
耳鼻咽喉 | 330篇 |
儿科学 | 1067篇 |
妇产科学 | 629篇 |
基础医学 | 4569篇 |
口腔科学 | 409篇 |
临床医学 | 3883篇 |
内科学 | 7066篇 |
皮肤病学 | 761篇 |
神经病学 | 3454篇 |
特种医学 | 1037篇 |
外国民族医学 | 1篇 |
外科学 | 4681篇 |
综合类 | 238篇 |
一般理论 | 29篇 |
预防医学 | 2738篇 |
眼科学 | 392篇 |
药学 | 1882篇 |
中国医学 | 65篇 |
肿瘤学 | 2244篇 |
出版年
2023年 | 104篇 |
2022年 | 195篇 |
2021年 | 557篇 |
2020年 | 478篇 |
2019年 | 864篇 |
2018年 | 977篇 |
2017年 | 805篇 |
2016年 | 811篇 |
2015年 | 1008篇 |
2014年 | 1227篇 |
2013年 | 1716篇 |
2012年 | 2014篇 |
2011年 | 2207篇 |
2010年 | 1418篇 |
2009年 | 1304篇 |
2008年 | 1920篇 |
2007年 | 1988篇 |
2006年 | 1937篇 |
2005年 | 1993篇 |
2004年 | 1920篇 |
2003年 | 1939篇 |
2002年 | 2000篇 |
2001年 | 320篇 |
2000年 | 261篇 |
1999年 | 333篇 |
1998年 | 399篇 |
1997年 | 370篇 |
1996年 | 294篇 |
1995年 | 330篇 |
1994年 | 270篇 |
1993年 | 259篇 |
1992年 | 186篇 |
1991年 | 195篇 |
1990年 | 172篇 |
1989年 | 143篇 |
1988年 | 153篇 |
1987年 | 163篇 |
1986年 | 144篇 |
1985年 | 140篇 |
1984年 | 153篇 |
1983年 | 122篇 |
1982年 | 176篇 |
1981年 | 173篇 |
1980年 | 154篇 |
1979年 | 96篇 |
1978年 | 102篇 |
1977年 | 92篇 |
1976年 | 74篇 |
1975年 | 64篇 |
1972年 | 67篇 |
排序方式: 共有10000条查询结果,搜索用时 328 毫秒
991.
992.
Lomonaco R Ortiz-Lopez C Orsak B Webb A Hardies J Darland C Finch J Gastaldelli A Harrison S Tio F Cusi K 《Hepatology (Baltimore, Md.)》2012,55(5):1389-1397
The role of adipose tissue insulin resistance in the pathogenesis of nonalcoholic fatty liver disease (NAFLD) remains unclear. To evaluate this, we measured in 207 patients with NAFLD (age = 51 ± 1, body mass index = 34.1 ± 0.3 kg/m(2) ) and 22 controls without NAFLD (no NAFLD) adipose tissue insulin resistance by means of a validated index (Adipo-IR(i) = plasma free fatty acids [FFA] x insulin [FPI] concentration) and as the suppression of plasma FFA during an oral glucose tolerance test and by a low-dose insulin infusion. We also explored the relationship between adipose tissue insulin resistance with metabolic and histological parameters by dividing them based on quartiles of adipose tissue insulin resistance (Adipo-IR(i) quartiles: Q1 = more sensitive; Q4 = more insulin resistant). Hepatic insulin resistance, measured as an index derived from endogenous glucose production x FPI (HIRi), and muscle insulin sensitivity, were assessed during a euglycemic insulin clamp with 3-[(3) H] glucose. Liver fat was measured by magnetic resonance imaging and spectroscopy, and a liver biopsy was performed to assess liver histology. Compared to patients without steatosis, patients with NAFLD were insulin resistant at the level of adipose tissue, liver, and skeletal muscle and had higher plasma aspartate aminotransferase and alanine aminotransferase, triglycerides, and lower high-density lipoprotein cholesterol and adiponectin levels (all P < 0.01). Metabolic parameters, hepatic insulin resistance, and liver fibrosis (but not necroinflammation) deteriorated as quartiles of adipose tissue insulin resistance worsened (all P < 0.01). CONCLUSION: Adipose tissue insulin resistance plays a key role in the development of metabolic and histological abnormalities of obese patients with NAFLD. Treatment strategies targeting adipose tissue insulin resistance (e.g., weight loss and thiazolidinediones) may be of value in this population. 相似文献
993.
994.
995.
Calland N Albecka A Belouzard S Wychowski C Duverlie G Descamps V Hober D Dubuisson J Rouillé Y Séron K 《Hepatology (Baltimore, Md.)》2012,55(3):720-729
Here, we identify (-)-epigallocatechin-3-gallate (EGCG) as a new inhibitor of hepatitis C virus (HCV) entry. EGCG is a flavonoid present in green tea extract belonging to the subclass of catechins, which has many properties. Particularly, EGCG possesses antiviral activity and impairs cellular lipid metabolism. Because of close links between HCV life cycle and lipid metabolism, we postulated that EGCG may interfere with HCV infection. We demonstrate that a concentration of 50 μM of EGCG inhibits HCV infectivity by more than 90% at an early step of the viral life cycle, most likely the entry step. This inhibition was not observed with other members of the Flaviviridae family tested. The antiviral activity of EGCG on HCV entry was confirmed with pseudoparticles expressing HCV envelope glycoproteins E1 and E2 from six different genotypes. In addition, using binding assays at 4°C, we demonstrate that EGCG prevents attachment of the virus to the cell surface, probably by acting directly on the particle. We also show that EGCG has no effect on viral replication and virion secretion. By inhibiting cell-free virus transmission using agarose or neutralizing antibodies, we show that EGCG inhibits HCV cell-to-cell spread. Finally, by successive inoculation of na?ve cells with supernatant of HCV-infected cells in the presence of EGCG, we observed that EGCG leads to undetectable levels of infection after four passages. CONCLUSION: EGCG is a new, interesting anti-HCV molecule that could be used in combination with other direct-acting antivirals. Furthermore, it is a novel tool to further dissect the mechanisms of HCV entry into the hepatocyte. 相似文献
996.
Michelsen MM Støttrup NB Schmidt MR Løfgren B Jensen RV Tropak M St-Michel EJ Redington AN Bøtker HE 《Basic research in cardiology》2012,107(3):260-9
Exercise protects against myocardial ischemia-reperfusion (I-R) injury but the mechanism remains unclear. Protection can be transferred from a remotely preconditioned human donor to an isolated perfused rabbit heart using a dialysate of plasma. We hypothesized that physical exercise preconditioning also confers cardioprotection through a humorally mediated effector dependent on opioid receptor activation. Thirteen male volunteers performed vigorous exercise (four 2-minute bouts of high-intensity exercise) and 1 week later they underwent remote ischemic preconditioning (four cycles of 5 min upper limb ischemia and reperfusion). Dialysates were prepared from blood collected before (control) and after the two interventions. Isolated rabbit hearts were perfused with the dialysates without and with co-administration of naloxone (opioid receptor antagonist) prior to 40 min regional ischemia and 2 h reperfusion. Exercise and remote ischemic preconditioning (rIPC) reduced infarct size from 60 ± 5 to 35 ± 5 % and from 57 ± 7 to 27 ± 3 % of the area at risk, respectively (p < 0.05 and < 0.01). Furthermore, post-ischemic left ventricular developed pressure was improved compared with controls (p = 0.08 for exercise and p = 0.04 for rIPC). Co-perfusion with naloxone abrogated the protective effects of exercise and remote ischemic preconditioned dialysates. In conclusion, high-intensity exercise preconditioning elicits cardioprotection through a humorally mediated dependent on opioid receptor activation, similar to rIPC. 相似文献
997.
998.
Pearce KF Lee SJ Haagenson M Petersdorf EW Norden J Collin MP Klein JP Spellman SR Lowerson SA Davies S Dickinson AM 《Haematologica》2012,97(7):1014-1019
Background
Allogeneic hematopoietic cell transplantation is the main curative therapy for patients with chronic myeloid leukemia who do not respond to tyrosine kinase inhibitors. It has been proposed that non-human leukocyte antigen gene polymorphisms influence outcome after hematopoietic cell transplantation and could be used alongside traditional patient-donor and transplant characteristics to create a recipient risk profile associated with allogeneic hematopoietic cell transplantation.Design and Methods
A previous study from the European Group for Blood and Marrow Transplantation showed that the absence of recipient tumor necrosis factor receptor II, absence of donor interleukin 10 ATA/ACC and presence of donor interleukin 1 receptor antagonist allele 2 genotypes were associated with decreased survival and increased non-relapse mortality in adult patients with chronic myeloid leukemia undergoing myeloablative human leukocyte antigen-identical sibling transplantation. To explore these associations in unrelated donor transplantation, these polymorphisms were genotyped in 383 adult patients with chronic myeloid leukemia who underwent hematopoietic cell transplantation from unrelated donors matched for 10/10 human leukocyte antigens.Results
The polymorphisms were not associated with overall survival, non-relapse mortality, relapse or acute graft-versus-host disease in the unrelated donor cohort. Comparison of the unrelated donor and human leukocyte antigen-identical sibling cohorts showed differences in survival and clinical characteristics.Conclusions
We did not confirm that non-human leukocyte antigen polymorphisms were associated with outcomes in myeloablative unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia, possibly because of the strong association between clinical variables and outcome which masked more subtle genetic effects. 相似文献999.
Hirsch P Tang R Marzac C Perrot JY Fava F Bernard C Jeziorowska D Marie JP Legrand O 《Haematologica》2012,97(2):241-245
ATP-binding cassette transporter (and specially P-glycoprotein) activity is a well known prognostic factor in acute myeloid leukemia, but when compared to other molecular markers its prognostic value has not been well studied. Here we study relationships between this activity, fms-like tyro-sine kinase 3(FLT3/ITD), nucleophosmin(NPM1), CAAT-enhancer binding protein alpha(CEBPα), and brain and acute leukemia cytoplasmic protein (BAALC), in 111 patients with normal cytogenetics who underwent the same treatment, and evaluate its prognostic impact. Independent factors for survival were age (P=0.0126), ATP-binding cassette transporter activity (P=0.018) and duplications in the fms-like tyrosine kinase 3 (P=0.0273). In the 66 patients without fms-like tyrosine kinase 3 duplication and without nucleophosmin mutation, independent prognostic factors for complete remission achievement and survival were age and ATP-binding cassette transporter activity. In conclusion, ATP-binding cassette transporter activity remains an independent prognostic factor, and could assist treatment decisions in patients with no nucleophosmin mutation and no fms-like tyrosine kinase 3 duplication. 相似文献
1000.
Rolla D Bellino D Pistoni G Peloso GC Rastaldi MP Simonini P Ravetti JL Cannella G 《Giornale italiano di nefrologia》2012,29(3):348-352
A novel lymphoproliferative disorder producing plasma cell expansion in the affected organ with fibrotic or sclerosing changes, known as 'IgG4-related disease', was defined in Japan by Umehara's group in 2010. We present the first case reported in Italy. In 2007, a 63-year-old man presented with epigastric pain and elevated serum lipase levels. Computed tomography of the abdomen revealed a Kuttner's tumor of the pancreas. The patient underwent a biliary-enteric anastomosis, and biopsy of the pancreas revealed massive infiltration of lymphocytes and plasma cells. The patient was diagnosed with chronic sclerosing pancreatitis. After one year, he began to show signs of sicca syndrome and at the same time developed progressive renal failure. Immunological tests revealed hypocomplementemia, and the renal biopsy specimen showed diffuse interstitial inflammation. The infiltrate was composed of lymphocytes, while infiltrating plasma cells showed immunoreactivity to IgG-4. Sialography using a radioisotope revealed severe involvement of the salivary glands, and Schirmer's test gave a positive result. This led us to diagnose hypocomplementemic tubulointerstitial nephritis in IgG4-related disease. Corticosteroid treatment resulted in rapid improvement including disappearance of the sicca syndrome and progressive amelioration of renal function. After six months, we discontinued steroid administration and started mycophenolate mofetil to maintain a low degree of immunosuppression. Follow-up after two years showed that this therapy continued to be quite effective in our patient. 相似文献